Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Matthew Shea
NDM

Matthew Shea

Needham
Wall Street Analyst
★★★★☆
#463
on 13Foresight · ranked by our own returns
65%
Success Rate
+7.6%
Average Return
11 of 17 calls profitable · +6.1% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 65% of Matthew Shea's ratings turned a profit when each position was held for 1 year — averaging +7.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

23 Buy 5 Hold 0 Sell
Matthew's Stock Coverage 7 ratings · 2026-11-05
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ALHC
Alignment Healthcare
 Oct 30, 2026 HOLD Buy
+109.7% avg upside
20 analysts
 — +4.0% ·
CLOV
Clover Health Investments
 Oct 28, 2026 BUY Hold
-6.6% avg upside
11 analysts
$6.00
34.45% Upside
 -9.9% ·
STLN
Starling Oncology Institute
 Oct 14, 2026 BUY Strong Buy
+12.8% avg upside
7 analysts
$9.00
37.76% Upside
 +0.3% ·
ASTH
Astrana Health
 Aug 07, 2026 BUY Strong Buy
+53.1% avg upside
17 analysts
$41.00
12.21% Upside
 +2.5% ·
AGL
Agilon Health
 Aug 06, 2026 HOLD Buy
-18.0% avg upside
26 analysts
 — +9.2% ·
EVH
Evolent Health
 Aug 06, 2026 BUY Strong Buy
+125.9% avg upside
19 analysts
$5.00
16.23% Upside
 +36.6% ·
PRVA
Privia Health Group
 May 07, 2026 BUY Strong Buy
+48.8% avg upside
26 analysts
$30.00
39.59% Upside
 -4.8% ·
🔒 2 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Matthew Shea — Frequently Asked Questions
How accurate are Matthew Shea's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Matthew's ratings were profitable over a one-year hold, with an average return of +8.4% per rating, or +6.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Matthew ranked on 13Foresight?
Matthew Shea is currently ranked #463 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Matthew cover?
Matthew most recently has ratings on ALHC, CLOV, STLN, ASTH, AGL, EVH, PRVA. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.